MCDS presented for the first time

Professor Mike Briggs presented the work behind MCDS-Therapy at Findacure’s Drug Repurposing for Rare Diseases conference.

As an academic-led, industry-free drug repurposing project for an ultra-rare disease, the MCDS-Therapy team is keen to spread the word of our work as far and wide as possible. Professor Mike Briggs, Project Coordinator, was invited to do just that at Findacure’s Drug Repurposing for Rare Diseases conference on 27th February 2018.

The conference was organised to showcase the excellent drug repurposing work being done across Europe in rare diseases. It was a perfect way to present the MCDS-Therapy project for the first time, and to announce receipt of funding from the European Union’s Horizon 2020 research grant. Over 100 people attended despite the snowy weather, including Dr Melita Irving who will be leading the MCDS-Project at the Guy’s and St Thomas’ Hospital trial site.

The conference was held in celebration of International Rare Disease Day, and gave Mike the chance to share our plans for MCDS-Therapy, and the journey to receive funding, with other academics, clinicians, patient groups, and life scientists.

Findacure, the organisation that arranged the conference, is another of the 11 MCDS partners. They are responsible for patient engagement, communication, and dissemination. You can find out more about the event by reading their conference blog. Alternatively you can listen to Mike’s talk in the video below.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *